Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involveα‐adrenoceptors
Sotiria Bexis, James R. Docherty
British Journal of Pharmacology February 20, 2006 DOI: 10.1038/sj.bjp.0706688 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Conscious rats |
| Interventions | MDMA MDA MDEA BRL 44408 |
| Dose | 20 mg kg −1 |
| Topics | MDMA |
| Keywords | Heart rate Blood pressure Pharmacology Anesthesia |
| Citations | 62 |
| Key findings | MDA produced the most marked and prolonged increase in blood pressure, while MDEA acted as an α1-adrenoceptor antagonist and showed the slowest recovery from hypothermia. |
Abstract
The effects of injection of 3,4‐methylenedioxymethamphetamine (MDMA), 3,4‐methylenedioxyamphetamine (MDA) and N ‐ethyl‐3,4‐methylenedioxyamphetamine (MDEA) (all 20 mg kg −1 ) on blood pressure, heart rate, core body temperature and locomotor activity in conscious rats were investigated using radiotelemetry. MDMA and MDA produced a prolonged increase in both systolic and diastolic pressures, with MDA causing the most marked rise. MDEA produced a transient but nonsignificant fall in diastolic pressure. The pressor response produced by MDA was accompanied by bradycardia. All three amphetamine derivatives caused an initial hypothermic response; however, MDA also produced a subsequent hyperthermia, and the speed of recovery from hypothermia was MDA>MDMA>MDEA. The α 2A ‐adrenoceptor antagonist 2‐((4,5‐dihydro‐1 H ‐imidazol‐2‐yl)methyl)‐2,3‐dihydro‐1‐methyl‐1 H ‐isoindole (BRL 44408) (1 mg kg −1 ) prolonged the hypothermic response to MDMA. Only MDA induced locomotor activity when given alone, but in the presence of BRL 44408, MDMA produced increased locomotor activity. The order of potency for producing isometric contractions of rat aorta ( α 1D ) and vas deferens ( α 1A ) was MDA>MDMA>MDEA, with MDEA acting as an α 1 ‐adrenoceptor antagonist with a p K B of 4.79±0.12 ( n =4) in aorta. The order of potency for prejunctional inhibition of stimulation‐evoked contractions in rat vas deferens ( α 2A ‐adrenoceptor mediated) was MDA>MDMA>MDEA. Blood pressure actions of the three amphetamine derivatives may be at least partly due to α 1 ‐adrenoceptor agonism or antagonism. The reversal of the hypothermic actions are at least partly due to α 2A ‐adrenoceptor agonism since the hypothermic response was more prolonged with MDEA which exhibits low α 2A ‐adrenoceptor potency, and effects of MDMA after α 2A ‐adrenoceptor antagonism were similar to those of MDEA. British Journal of Pharmacology (2006) 147 , 926–934. doi: 10.1038/sj.bjp.0706688
Comparable studies
Other preclinical and animal studies on MDMA, most cited first.
Citations in the library
Cited by 21
- The role of monoamines in the changes in body temperature induced by 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives British Journal of Pharmacology March 3, 2010
- The preclinical pharmacology of mephedrone; not justMDMAby another name British Journal of Pharmacology March 24, 2014
- Differential effects of cathinone compounds andMDMAon body temperature in the rat, and pharmacological characterization of mephedrone‐induced hypothermia British Journal of Pharmacology October 8, 2012
- Role of α1‐ and β3‐adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse British Journal of Pharmacology April 30, 2009
- Effects of 3,4‐methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats British Journal of Pharmacology October 12, 2013
and 16 more in the library
Cites 16
- Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat Journal of Neuroscience July 1, 1998
- The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype British Journal of Pharmacology August 1, 1995
- Cutaneous Vasoconstriction Contributes to Hyperthermia Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy) in Conscious Rabbits Journal of Neuroscience November 1, 2001
- Investigation of the prejunctional α2‐adrenoceptor mediated actions of MDMA in rat atrium and vas deferens British Journal of Pharmacology November 1, 1999
- Attenuation of 3,4‐methylenedioxymethamphetamine (MDMA, Ecstasy)‐induced rhabdomyolysis with α1‐ plus β3‐adrenoreceptor antagonists British Journal of Pharmacology June 1, 2004
and 11 more in the library